PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 25, 2016Circulation871 citationsOpen Access

Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device

View Full Paper
LBLuigi Di BiasePMPrasant MohantySMSanghamitra Mohanty

Key Points

Key points are not available for this paper at this time.

Abstract

URL: http://www.clinicaltrials.gov. Unique identifier: NCT00729911.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Biase et al. (2016) studied this question.

synapsesocial.com/papers/69d56c3d75589c71d767cd10https://doi.org/10.1161/circulationaha.115.019406
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Amiodarone prevention for atrial fibrillation relapse after surgical ablation2023
  2. 2Atrial Fibrillation in Heart Failure US Ambulatory Cardiology Practices and the Potential for Uptake of Catheter Ablation: An National Cardiovascular Data Registry (NCDR <sup>®</sup> ) Research to Practice (R2P) Project2017 · 9 citations
  3. 3The effect of amiodarone given periprocedurally on the effectiveness of catheter ablation in patients with persistent atrial fibrillation refractory to cardioversion2024
  4. 4Amiodarone reduces the amount of ablation during catheter ablation for persistent atrial fibrillation2014 · 16 citations
  5. 5Amiodarone in the management of refractory atrial fibrillation1987 · 8 citations